NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Accounts Payable

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) (NRSNW) currently reports a accounts payable of $800K as of December 2025. That compares with $1.2M in the prior-year period — down 31.1% year over year. Use the charts on this page to explore NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s accounts payable history and peer comparisons.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s accounts payable decreased from $1.2M to $800K — a 31.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NeuroSense Therapeutics Ltd - Warrants (09/11/2026) reported $800K in accounts payable as of December 2025. That compares with $1.2M in the prior-year period — down 31.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $800K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NeuroSense Therapeutics Ltd - Warrants (09/11/2026), and consider following NRSNW for alerts when major investors trade the stock.